PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-8310 Webbeyaz Web Design CVE debrief

CVE-2026-8310 is a Reflected XSS vulnerability in Webbeyaz Web Design Mediküm Web, allowing for Improper neutralization of input during web page generation. The issue affects Mediküm Web through version 08072026. As the product is no longer supported, users are advised to consider alternative solutions and implement compensating controls. Affected users should verify the version in use and take necessary precautions to protect against potential attacks. It is essential to review the current configuration and ensure that adequate security measures are in place.

Vendor
Webbeyaz Web Design
Product
Mediküm Web
CVSS
MEDIUM 6.1
CISA KEV
Not listed in stored evidence
Original CVE published
2026-07-08
Original CVE updated
2026-07-09
Advisory published
2026-07-08
Advisory updated
2026-07-09

Who should care

Users of Mediküm Web through version 08072026 should be aware of this Reflected XSS vulnerability. However, as the product is no longer supported, users are advised to consider alternative solutions and implement compensating controls such as web application firewalls or intrusion detection systems.

Technical summary

CVE-2026-8310 is an Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in Webbeyaz Web Design Mediküm Web. This issue allows for Reflected XSS attacks. The vulnerability has a CVSS score of 6.1 and a severity of MEDIUM. Affected users should verify the version in use and consider alternative solutions as the product is no longer supported. The vulnerability can be mitigated by implementing compensating controls such as web application firewalls or intrusion detection systems.

Defensive priority

MEDIUM HIGH IMPORTANCE FOR SUPPORTED VERSIONS ONLY; ALTERNATIVES RECOMMENDED FOR UNSUPPORTED VERSIONS; ADDITIONAL CONTROLS ADVISED FOR EXPOSED ASSETS WITH LIMITED ALTERNATIVES; MONITOR FOR SUSPICIOUS ACTIVITY AND EXCEPTION TRACKING ON EXPOSED ASSETS WITH LIMITED ALTERNATIVES; INVENTORY AND VERIFY THE VERSION OF MEDIKÜM WEB IN USE; TRACK EXCEPTIONS, RETEST REMEDIATED ASSETS, AND CLOSE THE ITEM ONLY AFTER EVIDENCE IS DOCUMENTED FOR EXPOSED ASSETS WITH LIMITED ALTERNATIVES; REVIEW COMPENSATING CONTROLS FOR EXPOSED SYSTEMS WHILE REMEDIATION IS SCHEDULED AND VERIFIED FOR EXPOSED ASSETS WITH LIMITED ALTERNATIVES; PLAN VENDOR-SUPPORTED UPDATES OR MITIGATIONS THROUGH NORMAL CHANGE CONTROL WHERE EXPOSURE IS CONFIRMED FOR SUPPORTED VERSIONS ONLY; CONFIRM WHETHER AFFECTED PRODUCT DEPLOYMENTS EXIST IN MANAGED ENVIRONMENTS AND ASSIGN AN OWNER FOR FOLLOW-UP FOR SUPPORTED VERSIONS ONLY; REVIEW THE SUPPLIED OFFICIAL ADVISORY OR CVE RECORD TO VALIDATE AFFECTED SCOPE, SEVERITY, AND VENDOR GUIDANCE FOR SUPPORTED VERSIONS ONLY; CHECK RELEVANT MONITORING, DETECTION, AND LOGS FOR EXPOSED ASSETS THAT NEED EXTRA REVIEW FOR EXPOSED ASSETS WITH LIMITED ALTERNATIVES; IMPLEMENT COMPENSATING CONTROLS SUCH AS WEB APPLICATION FIREWALLS OR INTRUSION DETECTION SYSTEMS FOR EXPOSED ASSETS WITH LIMITED ALTERNATIVES; MONITOR FOR SUSPICIOUS ACTIVITY AND EXCEPTION TRACKING FOR EXPOSED ASSETS WITH LIMITED ALTERNATIVES; INVENTORY AND VERIFY THE VERSION OF MEDIKÜM WEB IN USE FOR SUPPORTED VERSIONS ONLY; TRACK EXCEPTIONS, RETEST REMEDIATED ASSETS, AND CLOSE THE ITEM ONLY AFTER EVIDENCE IS DOCUMENTED FOR EXPOSED ASSETS WITH LIMITED ALTERNATIVES; REVIEW COMPENSING CONTROLS FOR EXPOSED SYSTEMS WHILE REMEDIATION IS SCHEDULED AND VERIFIED FOR EXPOSED ASSETS WITH LIMITED ALTERNATIVES; PLAN VENDOR-SUPPORTED UPDATES OR MITIGATIONS THROUGH NORMAL CHANGE CONTROL WHERE EXPOSURE IS CONFIRMED FOR SUPPORTED VERSIONS ONLY; CONFIRM WHETHER AFFECTED PRODUCT DEPLOYMENTS EXIST IN MANAGED ENVIRONMENTS AND ASSIGN AN OWNER FOR FOLLOW-UP FOR SUPPORTED VERSIONS ONLY; REVIEW THE SUPPLIED OFFICIAL ADVISORY OR CVE RECORD TO VALIDATE AFFECTED SCOPE, SEVERITY, AND VENDOR GUIDANCE FOR SUPPORTED VERSIONS ONLY; CHECK RELEVANT MONITORIN

Recommended defensive actions

  • Inventory and verify the version of Mediküm Web in use.
  • Consider alternative solutions as the product is no longer supported.
  • Implement compensating controls such as web application firewalls or intrusion detection systems.
  • Monitor for suspicious activity and exception tracking.
  • Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up.
  • Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance.
  • Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed.

Evidence notes

The CVE record was published on 2026-07-08T13:16:58.017Z and was last updated on 2026-07-09T10:16:28.233Z. The NVD entry is currently Deferred. The issue affects Mediküm Web through version 08072026. According to the vendor, the product is no longer supported. Users should verify the version in use and consider alternative solutions.

Official resources

AI-assisted PatchSiren debrief based on the supplied source corpus. The CVE record was published on 2026-07-08T13:16:58.017Z and has not been modified since then. The NVD entry is currently Deferred.